BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 35195668)

  • 1. Implications of Satellitosis or In-transit Metastasis in Cutaneous Squamous Cell Carcinoma: A Prognostic Omission in Cancer Staging Systems.
    Smile TD; Ruiz ES; Kus KJB; Murad F; Wei W; Xiong DD; Vidimos AT; Schmults CD; Koyfman SA
    JAMA Dermatol; 2022 Apr; 158(4):390-394. PubMed ID: 35195668
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disease Progression in Cutaneous Squamous Cell Carcinoma Patients With Satellitosis and In-transit Metastasis.
    Smile TD; Xiong DX; Varra V; Winter IW; Beal BT; Gastman BR; Geiger JL; Adelstein DJ; Bergfeld WF; Piliang MP; Billings SD; Ko JS; Knackstedt TJ; Lucas JL; Poblete-Lopez CM; Meine JG; Vij A; Vidimos AT; Koyfman SA
    Anticancer Res; 2021 Jan; 41(1):289-295. PubMed ID: 33419823
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic factors for satellitosis or in-transit metastasis in cutaneous squamous cell carcinoma: A multicentric cohort study.
    Marti-Marti I; Podlipnik S; Cañueto J; Ferrándiz-Pulido C; Deza G; Sanmartín O; Jaka A; Beà-Ardèbol S; Botella-Estrada R; Redondo P; Turrión-Merino L; Ruiz-Salas V; Masferrer E; Yébenes M; Sánchez-Schmidt JM; Gracia-Darder I; Altemir-Vidal A; Aguayo-Ortiz RS; Becerril S; Bodet-Castillo D; Leal L; Fuente MJ; Moreno-Arrones OM; Abril-Pérez C; Tomás-Velázquez A; Sandoval-Clavijo A; Toll A
    J Am Acad Dermatol; 2023 Jul; 89(1):119-127. PubMed ID: 36907554
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcomes of Patients With Multiple Cutaneous Squamous Cell Carcinomas: A 10-Year Single-Institution Cohort Study.
    Levine DE; Karia PS; Schmults CD
    JAMA Dermatol; 2015 Nov; 151(11):1220-5. PubMed ID: 26177278
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extensive Perineural Invasion vs Nerve Caliber to Assess Cutaneous Squamous Cell Carcinoma Prognosis.
    Massey PR; Wang DM; Murad F; Mulvaney P; Moore K; Okhovat JP; Russell-Goldman E; Lin WM; Piris A; Huilgol SC; Ruiz ES; Schmults CD
    JAMA Dermatol; 2023 Dec; 159(12):1332-1338. PubMed ID: 37851425
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term clinical outcomes of patients with invasive cutaneous squamous cell carcinoma treated with Mohs micrographic surgery: A 5-year, multicenter, prospective cohort study.
    Tschetter AJ; Campoli MR; Zitelli JA; Brodland DG
    J Am Acad Dermatol; 2020 Jan; 82(1):139-148. PubMed ID: 31279037
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of AJCC tumor staging for cutaneous squamous cell carcinoma and a proposed alternative tumor staging system.
    Jambusaria-Pahlajani A; Kanetsky PA; Karia PS; Hwang WT; Gelfand JM; Whalen FM; Elenitsas R; Xu X; Schmults CD
    JAMA Dermatol; 2013 Apr; 149(4):402-10. PubMed ID: 23325457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validating 4 Staging Systems for Cutaneous Squamous Cell Carcinoma Using Population-Based Data: A Nested Case-Control Study.
    Roscher I; Falk RS; Vos L; Clausen OPF; Helsing P; Gjersvik P; Robsahm TE
    JAMA Dermatol; 2018 Apr; 154(4):428-434. PubMed ID: 29516080
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of Disease Recurrence With Survival Outcomes in Patients With Cutaneous Squamous Cell Carcinoma of the Head and Neck Treated With Multimodality Therapy.
    Sun L; Chin RI; Gastman B; Thorstad W; Yom SS; Reddy CA; Nussenbaum B; Wang SJ; Knackstedt T; Vidimos AT; Koyfman SA; Manyam BV
    JAMA Dermatol; 2019 Apr; 155(4):442-447. PubMed ID: 30810715
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nationwide Incidence of Metastatic Cutaneous Squamous Cell Carcinoma in England.
    Venables ZC; Autier P; Nijsten T; Wong KF; Langan SM; Rous B; Broggio J; Harwood C; Henson K; Proby CM; Rashbass J; Leigh IM
    JAMA Dermatol; 2019 Mar; 155(3):298-306. PubMed ID: 30484823
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cutaneous Squamous Cell Carcinoma: A Review of High-Risk and Metastatic Disease.
    Burton KA; Ashack KA; Khachemoune A
    Am J Clin Dermatol; 2016 Oct; 17(5):491-508. PubMed ID: 27358187
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stratification of Poor Outcomes for Cutaneous Squamous Cell Carcinoma in Immunosuppressed Patients Using the American Joint Committee on Cancer Eighth Edition and Brigham and Women's Hospital Staging Systems.
    Blechman AB; Carucci JA; Stevenson ML
    Dermatol Surg; 2019 Sep; 45(9):1117-1124. PubMed ID: 30640779
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical outcomes of high-risk cutaneous squamous cell carcinomas treated with Mohs surgery alone: An analysis of local recurrence, regional nodal metastases, progression-free survival, and disease-specific death.
    Soleymani T; Brodland DG; Arzeno J; Sharon DJ; Zitelli JA
    J Am Acad Dermatol; 2023 Jan; 88(1):109-117. PubMed ID: 35760236
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Role of Total Parotidectomy for Metastatic Cutaneous Squamous Cell Carcinoma and Malignant Melanoma.
    Thom JJ; Moore EJ; Price DL; Kasperbauer JL; Starkman SJ; Olsen KD
    JAMA Otolaryngol Head Neck Surg; 2014 Jun; 140(6):548-54. PubMed ID: 24722863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recurrence and Mortality Risk of Merkel Cell Carcinoma by Cancer Stage and Time From Diagnosis.
    McEvoy AM; Lachance K; Hippe DS; Cahill K; Moshiri Y; Lewis CW; Singh N; Park SY; Thuesmunn Z; Cook MM; Alexander NA; Zawacki L; Thomas H; Paulson KG; Nghiem P
    JAMA Dermatol; 2022 Apr; 158(4):382-389. PubMed ID: 35195657
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Staging cutaneous squamous cell carcinoma metastases to the parotid gland.
    Czerwonka L; De Santis RJ; Horowitz G; Hong M; Orsini M; Enepekides D; Goldstein DP; Dort J; Higgins K
    Laryngoscope; 2017 Sep; 127(9):2063-2069. PubMed ID: 28295401
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Major prognostic factors for recurrence and survival independent of the American Joint Committee on Cancer eighth edition staging system in patients with cutaneous squamous cell carcinoma treated with multimodality therapy.
    Xu MJ; Lazar AA; Garsa AA; Arron ST; Ryan WR; El-Sayed IH; George JR; Algazi AP; Heaton CM; Ha PK; Yom SS
    Head Neck; 2018 Jul; 40(7):1406-1414. PubMed ID: 29524273
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors Associated with Recurrence and Regional Adenopathy for Head and Neck Cutaneous Squamous Cell Carcinoma.
    Harris BN; Bayoumi A; Rao S; Moore MG; Farwell DG; Bewley AF
    Otolaryngol Head Neck Surg; 2017 May; 156(5):863-869. PubMed ID: 28322123
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Staging for cutaneous squamous cell carcinoma as a predictor of sentinel lymph node biopsy results: meta-analysis of American Joint Committee on Cancer criteria and a proposed alternative system.
    Schmitt AR; Brewer JD; Bordeaux JS; Baum CL
    JAMA Dermatol; 2014 Jan; 150(1):19-24. PubMed ID: 24226651
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A multi-institutional comparison of outcomes of immunosuppressed and immunocompetent patients treated with surgery and radiation therapy for cutaneous squamous cell carcinoma of the head and neck.
    Manyam BV; Garsa AA; Chin RI; Reddy CA; Gastman B; Thorstad W; Yom SS; Nussenbaum B; Wang SJ; Vidimos AT; Koyfman SA
    Cancer; 2017 Jun; 123(11):2054-2060. PubMed ID: 28171708
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.